ALLISON EBERLE: Open Payments
NPI 1073143301 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 9 payments from 6 companies in 2025. Trend: 2023 $45 · 2024 $137 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $149 |
| GENZYME CORPORATION | 1 | $133 |
| PFIZER INC. | 1 | $91 |
| UCB, Inc. | 2 | $66 |
| Janssen Biotech, Inc. | 1 | $30 |
| Smith+Nephew, Inc. | 1 | $14 |
Products named: WAYRILZ, RINVOQ, LITFULO, Bimzelx, TREMFYA, MAVYRET, COLLAGENASE SANTYL.
Industry payments across IN — which companies pay providers there.
